Advance in the sulfur-based electron donor autotrophic denitrification for nitrate nitrogen removal from wastewater.

In the field of wastewater treatment, nitrate nitrogen (NO3--N) is one of the significant contaminants of concern. Sulfur autotrophic denitrification technology, which uses a variety of sulfur-based electron donors to reduce NO3--N to nitrogen (N2) through sulfur autotrophic denitrification bacteria, has emerged as a novel nitrogen removal technology to replace heterotrophic denitrification in the field of wastewater treatment due to its low cost, environmental friendliness, and high nitrogen removal efficiency. This paper reviews the advance of reduced sulfur compounds (such as elemental sulfur, sulfide, and thiosulfate) and iron sulfides (such as ferrous sulfide, pyrrhotite, and pyrite) electron donors for treating NO3--N in wastewater by sulfur autotrophic denitrification technology, including the dominant bacteria types and the sulfur autotrophic denitrification process based on various electron donors are introduced in detail, and their operating costs, nitrogen removal performance and impacts on the ecological environment are analyzed and compared. Moreover, the engineering applications of sulfur-based electron donor autotrophic denitrification technology were comprehensively summarized. According to the literature review, the focus of future industry research were discussed from several aspects as well, which would provide ideas for the application and optimization of the sulfur autotrophic denitrification process for deep and efficient removal of NO3--N in wastewater.

Ferula sinkiangensis against gastric cancer: a network pharmacology, molecular docking and cell experiment study.

Background: Ferula sinkiangensis (F. sinkiangensis) is a traditional Chinese medicine that has been used for thousands of years to treat stomach ailments. To identify the main active compounds and explore the mechanisms underlying the therapeutic effect of F. sinkiangensis against gastric cancer (GC) by network pharmacology, molecular docking analysis and cell experiment. Methods: Based on a review of the literature and previous experiments conducted by our research group, the active compounds of F. sinkiangensis were obtained. Active compounds and their target genes were screened from SwissADME, Pubchem, and Pharmmapper databases. GC-related target genes were obtained from GeneCards. The drug-compound-target-disease (D-C-T-D) network and protein-protein interaction (PPI) network were constructed by Cytoscape 3.7.2 and STRING database, and the core target genes and core active compounds were identified. Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were conducted using the R package clusterProfiler. The core genes with high expression in GC were screened, which correlated with a poor prognosis using the GEPIA, UALCAN, HPA, and KMplotter databases. KEGG signaling pathway analysis was further conducted to predict the mechanism of F. sinkiangensis during the process of GC inhibition. The AutoDock vina 1.1.2 program was used to verify the molecular docking of the core active compounds and core target genes. MTT, Transwell, and Wound healing assay were used to detect the effects of ethyl acetate extract of F. sinkiangensis on the proliferation, invasion, and apoptosis of GC cells. Results: Final results indicated that the active compounds include Farnesiferol C, Assafoetidin, Lehmannolone, Badrakemone, etc. The identified core target genes were GPI, TKT, GLYCTK, ERBB2, GAPDH, etc. The Glycolysis/Gluconeogenesis pathway and the Pentose Phosphate pathway might play important roles in the treatment of GC with F. sinkiangensis. The data from the study showed that F. sinkiangensis was able to inhibit the proliferation of GC cells. Meanwhile, F. sinkiangensis remarkedly repressed the invasion and migration of GC cells in in vitro experiment. Conclusions: This study revealed that F. sinkiangensis has an antitumor effect in in vitro experiment, and that the mechanism of F. sinkiangensis in GC treatment shows characteristics of multi-components, multi-targets, and multi-pathways, which provides a theoretical basis for its clinical application and subsequent experimental verification.

Influence of Rotational Speed on Isothermal Piston Compression System.

An isothermal piston is a device that can achieve near-isothermal compression by enhancing the heat transfer area with a porous media. However, flow resistance between the porous media and the liquid is introduced, which cannot be neglected at a high operational speed. Thus, the influence of rotational speed on the isothermal piston compression system is analyzed in this study. A flow resistance mathematical model is established based on the face-centered cubic structure hypothesis. The energy conservation rate and efficiency of the isothermal piston are defined. The effect of rotational speed on resistance is discussed, and a comprehensive energy conservation performance assessment of the isothermal piston is analyzed. The results show that the increasing rate of the resistance work increases significantly proportional to the rotational speed, and the proportion of resistance work in the total work increases gradually and sharply. The total work including compression and resistance cannot be larger than the compression work under adiabatic conditions. The maximum rotational speed is 650 rpm.

Synthesis of flower-like MnO2 nanostructure with freshly prepared Cu particles and electrochemical performance in supercapacitors.

Four types of flowerlike manganese dioxide in nano scale was synthesized via a liquid phase method in KMnO4-H2SO4 solution and Cu particles, wherein the effect of Cu particles was investigated in detail. The obtained manganese dioxide powder was characterized by XRD, SEM and TEM, and the supercapacity properties of MnO2 electrode materials were measured. The results showed that doping carbon black can benefit to better dispersion of copper particles, resulting in generated smaller size of Cu particles, and the morphology of MnO2 nanoparticles was dominated by that of Cu particles. The study of MnO2 synthesis by different sources of Cu particles showed that the size of MnO2 particles decreased significantly with freshly prepared fine copper powder compared with using commercial Cu powder, and the size of MnO2 particles can be further reduced to 120 nm by prepared Cu particles with smaller size. Therefore, it was suggested that the copper particles served as not only the reductant and but also the nuclei centre for the growth of MnO2 particles in synthesis process MnO2, and that is the reason how copper particles worked on the growth of flower-like MnO2 and electrochemical property. In the part of investigation for electrochemical property, the calculated results of b values indicated that the electrode materials have pseudo capacitance property, and the highest specific capacitance of 197.2 F g-1 at 2 mV s-1 and 148 F/g at 1 A/g were obtained for MCE electrode materials (MnO2 was synthesized with freshly prepared copper particles, where carbon black was used and dispersed in ethanol before preparation of Cu particles). The values of charge transfer resistance in all types of MnO2 materials electrodes were smaller than 0.08 Ω. The cycling retention of MCE material electrode is still kept as 93.8% after 1000 cycles.

The Inhibitory Effect and Mechanism of Ferula akitschkensis Volatile Oil on Gastric Cancer.

Ferula akitschkensis volatile oil (FAVO) has a good inhibitory activity on gastric cancer cell proliferation, but the mechanism of action is not yet clear. In this study, we tested the antigastric cancer efficacy and mechanism of FAVO using both in vivo and in vitro models. The results showed that FAVO effectively inhibited the proliferation, migration, and invasion of human gastric cancer SGC-7901 cells, the formation of small tubules of human umbilical vein endothelial cells as well as zebrafish intersegmental vessel and intestinal vein angiogenesis. In vivo experiments showed that FAVO significantly delayed the growth of SGC-7901 tumor-bearing nude mice and induced higher serum IL-2 and IFN-γ and reduced serum IL-6. Western blot results showed that FAVO reduced the expression of HIF-2α, VEGF, VEGFR2, P-VEGFR2, Akt, and P-Akt in SGC-7901 cells with CoCl2 induced hypoxia. We further clarified the main chemical components of FAVO through GC-MS analysis. In summary, FAVO may inhibit tumor growth and angiogenesis via inhibiting the HIF-2α/VEGF signaling pathway.

Short-term oral corticosteroids for initial treatment of moderate-to-severe persistent asthma: A double-blind, randomized, placebo-controlled trial.

BACKGROUND AND PURPOSE: The purpose of this study was to investigate that on the basis of ICS-LABA treatment, whether or not adding on short course of oral corticosteroid could increase the rate of asthma control. METHODOLOGY: This was a double blind, randomized controlled study. Patients with moderate to severe persistent asthma who are maintenance treatment naïve were recruited from the out-patients clinic. All patients included in the study received ICS-LABA as initial treatment. Two weeks oral corticosteroid or placebo were added on at the beginning of treatment. All the subjects were followed-up by daily measurement of PEF and asthma diary for 12 week and spirometry at 4 weeks and 12 weeks. RESULTS: 13 cases were randomized to Corticosteroid group (M/F: 9/4, age: 45.0 ± 5.0 yrs), 11 to Placebo group (M/F: 4/7, age: 35.7 ± 9.6yrs). After treatment, significant improvement in ACT、ACQ、AQLQ、FEV1、FEV1% were observed in both groups as compared with baseline data (all P < 0.05). However, there were no significant difference between two groups in the improvement of ACT、ACQ、AQLQ、FEV1、FEV1% (all P > 0.05). After 4 weeks of treatment, total control was achieved in 3 (30.8%) in corticosteroid group and 2 (18.2%) in placebo group; Partial control was achieved in 7 (61.5%)in corticosteroid group and in 7 (63.6%) in placebo group. There was no significant difference in control rates between two groups (X2 = 0.919, P = 0.632). Similar findings were observed after 12 weeks of treatment. CONCLUSION: In maintenance treatment naïve moderate to severe persistent asthma, ICS-LABA therapy was adequate initial treatment for achieving asthma control in majority of the patients. Add on short course of oral corticosteroid provided no significant clinical benefit.

A review on Fenton process for organic wastewater treatment based on optimization perspective.

Water pollution caused by organic wastewater has become a serious concern worldwide. Fenton oxidation process is one of the most effective and suitable methods for the abatement of organic pollutants. However, the process has three obvious shortcomings: the narrow working pH range, the high costs and risks associated with handling, transportation and storage of reagents (H2O2 and catalyst), the significant iron sludge related second pollution. In order to overcome these shortcomings, various optimized Fenton processes have been widely studied. Therefore, a summary of the study status of Fenton optimization processes is necessary to develop a novel and high efficiency organic wastewater treatment method. Based on the optimization perspective, taking shortcomings of Fenton process as a breakthrough, the fundamentals, advantages and disadvantages of single Fenton optimization processes (heterogeneous Fenton, photo-Fenton and electro-Fenton) for organic wastewater treatment were reviewed and the corresponding reaction mechanism diagrams were drawn in this paper. Then, the feasibility and application of the coupled Fenton optimization processes (photoelectro-Fenton, heterogeneous electro-Fenton, heterogeneous photoelectro-Fenton, three-dimensional electro-Fenton) for organic wastewater treatment were discussed in depth. Additionally, the effect of some important operation parameters (pH and catalyst, H2O2, organic pollutants concentration) on the degradation efficiency of organic pollutants was studied to provide guidance for the optimization of operation parameters. Finally, the possible future research directions for optimized Fenton processes were given. The review aims to assist researchers and engineers to gain fundamental understandings and critical view of Fenton process and its optimization processes, and hopefully with the knowledge it could bring new opportunities for the optimization and future development of Fenton process.

A randomized, double-blind, multicenter Phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia.

BACKGROUND/PURPOSE: To compare the clinical efficacy and safety of nemonoxacin with levofloxacin in treating community-acquired pneumonia (CAP) in a Phase II clinical trial. METHODS: One hundred ninety-two patients with CAP were randomized to receive oral nemonoxacin (500 mg or 750 mg) or levofloxacin (500 mg) once daily for 7-10 days. Clinical and bacteriological responses were determined at the test of cure (TOC) visit in the full analysis set (FAS). RESULTS: The clinical cure rate of nemonoxacin (500 mg), nemonoxacin (750 mg), and levofloxacin (500 mg) was 93.3%, 87.3%, and 88.5%, respectively, in the FAS (n = 168), and 93.0%, 93.9%, and 88.9%, respectively in the per protocol set (n = 152). At the TOC visit, nemonoxacin at 500 mg and 750 mg was proven to be noninferior to levofloxacin at 500 mg in the FAS in terms of clinical efficacy. The overall bacteriological success rate was 83.3% in both nemonoxacin groups and 80.0% in the levofloxacin 500 mg group in the bacteriological FAS. The comprehensive efficacy rate was comparable among the three groups (87.5% for the nemonoxacin 500 mg group, 93.8% for the nemonoxacin 750 mg group, and 81.3% for the levofloxacin 500 mg group). Most drug-related adverse events were mild and transient, mainly gastrointestinal symptoms such as nausea and vomiting, transient neutropenia, and elevated liver enzymes. No drug-related serious adverse events occurred. CONCLUSION: Either 500 mg or 750 mg of oral nemonoxacin taken once daily for 7-10 days demonstrated high clinical and bacteriological success rates in Chinese adult patients with CAP. Nemonoxacin at 500 mg once daily for 7-10 days is recommended for future Phase III clinical trials. ClinicalTrials.gov identifier: NCT01537250.

Several insights into the preprocessing of electrograms in atrial fibrillation for dominant frequency analysis.

BACKGROUND: Dominant frequency (DF) analysis of atrial electrograms has become an important method in characterizing atrial fibrillation (AF). As a classic method, Botteron's approach is widely used in the preprocessing of frequency analysis during AF. It includes three steps: (1) band-pass filtering at 40-250 Hz, (2) absolute value, and (3) low-pass filtering at 20 Hz. This paper aims to expound the necessity and adjustability of each step. METHODS AND RESULTS: Unipolar epicardial mapping signals were recorded during AF from eight mongrel dogs with cholinergic AF model. Episodes of these data were randomly selected to evaluate the impact of different pass bands and the necessity of low-pass filtering with 20 Hz cutoff frequency. Each episode of AF signal is 5 s long with a sampling rate of 2 kHz. Simulated electrograms were adopted to discuss the role of taking absolute value. Furthermore, direct spectral analysis method (FFT et al.) is compared with Botteron's preprocessing approach. According to our statistical analysis, the pass band of 40-250 Hz was not the best, while 20-100 Hz presented the high accuracy rate of DF. From the comparing result of direct FFT without Botteron's approach we deduced that the rectification of absolute value was meaningful for the fundamental atrial frequency. The final step, 20 Hz low-pass filter can completely be omitted in DF analysis. In consideration of the demand for real-time distribution of DF in clinical or experimental situations, down-sampling method and the impact of ventricular artifacts on DF was also discussed. CONCLUSION: In the actual application of the three preprocessing steps, the pass band selection of band-pass filter can be adjusted and the rectification of taking absolute value is important. Nevertheless, the final step of 20 Hz low-pass filter is totally unnecessary. In real-time signal processing situations, taking down-sampling method and ignoring the ventricular artifacts can also have high performance in DF analysis of atrial electrograms.

Examination of daytime sleepiness and cognitive performance testing in patients with primary insomnia.

OBJECTIVE: While individuals with insomnia consistently complain of cognitive impairment, previous studies on the effect of insomnia on objective measures of cognitive function have obtained ambiguous results. The relationship between daytime sleepiness and cognitive manifestations in insomnia patients is not clear. METHODS: Thirty-six primary insomnia patients (PIPs) and 26 good sleep controls (GSCs) with age and gender matched manner were included in the study. Participants underwent an overnight polysomnography followed by a multiple sleep latency test (MSLT) and an examination of the attention network test (ANT). ANT reflected three attentional networks including alerting, orienting and executive control. According to whether accompanied with excessive daytime sleepiness (EDS), the insomnia group were subdivided into PIPs with EDS (n = 12, score on MSLT<10 min) and PIPs without EDS (n = 24, score on MSLT≥10 min). RESULTS: PIPs only performed worse on executive control function than GSCs in ANT. PIPs with EDS had longer overall reaction time (RT) related to PIPs without EDS. Further analyses with Pearson correlation analysis showed a significant negative correlation between the overall RT and MSLT latency in insomniacs (r = -0.444, p<0.01), whereas no such correlation was found in controls. CONCLUSIONS: Results suggest that PIPs do show executive control function deficits compared with GSCs. Daytime sleepiness in terms of MSLT latency was associated with poor cognitive manifestations in patients with insomnia.

[The role of actigraphy in monitoring sleep and sleep disorders].

The use of actigraphy, which can be used to estimate sleep-wake patterns from activity levels, has become common in sleep research. Actigraphy is a simple, cost-effective and non-invasive method for healthcare providers and researchers to assess patients sleep quality and screen for potential sleep disorders in recent years. But, there is no wide recognition and application of actigraphy in China up till now. This review summarized the application of actigraphy in evaluation of sleep and diagnosis of sleep disorders.

TGF-beta1 induces human bronchial epithelial cell-to-mesenchymal transition in vitro.

The subepithelial fibrosis component of airway remodeling in asthma is mediated through induction of transforming growth factor-beta1 (TGF-beta1) expression with consequent activation of myofibroblasts to produce extracellular matrix proteins. The number of myofibroblasts is increased in the asthmatic airway and is significantly correlated with the thickness of lamina reticularis. However, much is still unknown regarding the origin of bronchial myofibroblasts. Emerging evidence suggests that myofibroblasts can derive from epithelial cells by an epithelial-to-mesenchymal transition (EMT). In this study we investigated whether TGF-beta1 could induce bronchial epithelial EMT in the human bronchial epithelial cell. Cultured human bronchial epithelial cells, 16HBE-14o, were stimulated with 10 ng/ml TGF-beta1. Morphologic changes were observed and stress fiber by actin reorganization was detected by indirect immunostaining. The expression of alpha-SMA (alpha-smooth muscle actin) and the epithelial cell marker E-cadherin were detected in those 16HBE-14o cells after TGF-beta1 stimulation for 72 h, using immunostaining and RT-PCR. The contents of collagen I were determined by radioimmunoassay, and the levels of endogenous TGF-beta1 were measured with ELISA. Human bronchial epithelial cells stimulated with TGF-beta1 were converted from a "cobblestone" epithelial structure into an elongated fibroblast-like shape. Incubation of human bronchial epithelial cells with TGF-beta1 induced de novo expression of alpha-SMA, increased formation of stress fiber by F-actin reorganization, and loss of epithelial marker E-cadherin. Moreover, a significant increase in the levels of collagen I and endogenous TGF-beta1 released from bronchial epithelial cells stimulated with TGF-beta1 were observed. These results suggested that human bronchial epithelial cells, under stimulation of TGF-beta1, underwent transdifferentiation into myofibroblasts.

[The investigation of the relationship between Leptin-insulin resistance and pulmonary function in patients with chronic obstructive pulmonary disease with acute exacerbation].

OBJECTIVE: To investigate the relationship between Leptin-insulin resistance and pulmonary function in patients with chronic obstructive pulmonary disease (COPD) with acute exacerbation. METHODS: Fifty-six patients with COPD with acute exacerbation were divided into two groups according to the fasting plasma glucose level [the hyperglycemia group: fasting blood glucose (FBG)> or =6.2 mmol/L, n=42. the hypoglycemia group: FBG 3.1-6.2 mmol/L, n=14], and 20 normal healthy controls [the control group, FBG (5.49+/-1.06) mmol/L)] were also included in the study. All patients had complete data of FBG, C-reactive protein (CRP), albumin (ALB), Leptin, fasting serum insulin (FISN), counting insulin sensitivity index (ISI), and pulmonary function tests [forced expiratory volume in one second (FEV1), FEV1 in percentage of forced vital capacity (FEV1/FVC), peak expiratory flow (PEF), maximal mid-expiratory flow (MMEF), total respiratory impedance (Zrs), airway resistance at 5, 20 Hz (R5, R20), airway resistance of capacitance and inertance at 5, 20 Hz (X5, X20), core resistance (Rc), periphery resistance (Rp), frequency resonant (Fres)]. RESULTS: The FBG, FISN, CRP were significantly higher and body mass index (BMI), ALB, ISI were significantly lower in the hyperglycemia group compared with control group (all P<0.01), but there was no difference in Leptin level (P>0.05). However, BMI, ALB, Leptin, ISI were significantly decreased and CRP, FISN were significantly increased in hypoglycemia group compared with the control group (P<0.05 or P<0.01). FBG, FISN, Leptin, CRP were significantly higher and ISI was significantly lower in hyperglycemia group compared with the hypoglycemia group (all P<0.01), but there was no significant difference in BMI and ALB (both P>0.05). The serum levels of Leptin was significantly positively correlated with Zrs, R5, R20, Rc, BMI (all P<0.01), and with significantly negative correlations with FEV1, X20 (P<0.01 and P<0.05), but had no correlation with FEV1/FVC, PEF, MMEF, X5, Rp, Fres (all P>0.05). ISI had significant positive correlations with FEV1/FVC, FEV1, PEF, MMEF (P<0.05 or P<0.01), but it had significant negative correlations with Zrs, R5, R20, X5, Rc, Rp, X20, BMI (P<0.05 or P<0.01), and no correlation with Fres. Multiple organ failure (MOF) was found in 6 cases (14%) in hyperglycemia group, one case (7%) was found in the second group, the incidence of MOF in hyperglycemia group was significantly higher compared with the hypoglycemia group (P<0.01). The length of hospital stay was prolonged in hyperglycemia group, compared with hypoglycemia group [(25.00+/-0.13) days vs. (17.93+/-0.22) days, P<0.01]. CONCLUSION: High glucose and Leptin-insulin resistance may aggravate the impairment of pulmonary function, prolong the length of hospital stay in the patient with COPD.